Category - Executive Moves

Executive Moves

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Peter Greenleaf as CEO, and George Milne Jr. as chairman of the board.

April 12, 2019

Executive Moves

Wedbush names Laura Chico as SVP of healthcare equity research

Wedbush Securities appointed Laura Chico, SVP of equity research on the healthcare and biotech team.

April 2, 2019

Executive Moves

iBio names industry veteran Thomas Isett to board

iBio (NYSE AMERICAN:IBIO) appointed Thomas Isett as a director, effective immediately.

April 1, 2019

Executive Moves

Celyad promotes Filippo Petti to CEO

Celyad SA (NASDAQ:CYAD) of Belgium named Filippo Petti, currently CFO, to the post of CEO, effective April 1, 2019.

March 29, 2019

Executive Moves

Roth promotes Yasmeen Rahimi to co-head biotech research

Roth Capital Partners promoted Yasmeen Rahimi, managing director and senior research analyst, to the position of co-head of biotechnology research.

March 28, 2019

Executive Moves

BriaCell Therapeutics names two biopharma experts to its board

BriaCell Therapeutics (TSV-V:BCT; OTCQB:BCTXF) appointed Dr. Rebecca Taub and Vaughn Embro-Pantalony as directors, and current board members Dr. Saeid Babaei, Rahoul Sharan, and Martin Schmieg have resigned, effective...

March 18, 2019

Executive Moves

C4 Therapeutics appoints Adam Crystal as CMO

C4 Therapeutics appointed a new CMO, Dr. Adam Crystal, to oversee clinical development of its pipeline of protein degrader-based therapeutics.

March 14, 2019

Executive Moves

BioSig appoints Barry Keenan as VP of engineering

BioSig Technologies (NASDAQ:BSGM) named Barry Keenan as VP of engineering to head up the company’s advanced product development.

March 6, 2019

Executive Moves

Roth names Tony Butler as head of biotech research

Roth Capital Partners appointed Charles “Tony” Butler as a managing director, senior research analyst and head of biotechnology research, and a partner.

February 21, 2019

Executive Moves

IntelGenx names Rodolphe Obeid as VP of operations

IntelGenx Technologies (TSXV:IGX; OTCQX:IGXT) appointed Dr. Rodolphe Obeid as VP of operations to oversee manufacturing, packaging, facilities and maintenance, production planning and supply chain management.

February 8, 2019

Category - Executive Moves

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Wedbush names Laura Chico as SVP of healthcare equity research

iBio names industry veteran Thomas Isett to board

Celyad promotes Filippo Petti to CEO

Roth promotes Yasmeen Rahimi to co-head biotech research

BriaCell Therapeutics names two biopharma experts to its board

C4 Therapeutics appoints Adam Crystal as CMO

BioSig appoints Barry Keenan as VP of engineering

Roth names Tony Butler as head of biotech research

IntelGenx names Rodolphe Obeid as VP of operations

General

More